Common Contracts
8 similar Underwriting Agreement contracts by Mobiquity Technologies, Inc., RanMarine Technology B.V., 60 Degrees Pharmaceuticals, Inc., others
RANMARINE TECHNOLOGY B.V. UNDERWRITING AGREEMENT [●] Units, Each Consisting ofUnderwriting Agreement • January 25th, 2024 • RanMarine Technology B.V. • Ship & boat building & repairing • New York
RANMARINE TECHNOLOGY B.V., a private company with limited liability under the laws of the Netherlands (besloten vennootschap met beperkte aansprakelijkheid) (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of [●] Units (the “Firm Units”), each Firm Unit consisting of: (i) [ ] American Depositary Shares (the “ADSs”), with each ADS representing [ ] ordinary shares, nominal value €0.01 per share (the “Firm ADSs”); (ii) one tradeable warrant to purchase [ ] ADS (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase [ ] ADS (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The [●] ADSs to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units
UNDERWRITING AGREEMENT [●] Units, Each Consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock; and [●] Pre-Funded Units, Each Consisting of One Pre-Funded Warrant to Purchase One Share of Common Stock and One...Underwriting Agreement • January 22nd, 2024 • 60 Degrees Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
An aggregate of [●] Units (the “Firm Units”), each Firm Unit consisting of: (i) one share of the Company’s common stock, $0.0001 par value per share (the “Common Stock”); and (ii) one non-tradeable warrant to purchase one share of Common Stock (the “Firm Non-Tradeable Warrants”); and
RANMARINE TECHNOLOGY B.V. UNDERWRITING AGREEMENT [●] Units, Each Consisting ofUnderwriting Agreement • December 21st, 2023 • RanMarine Technology B.V. • Ship & boat building & repairing • New York
RANMARINE TECHNOLOGY B.V., a private company with limited liability under the laws of the Netherlands (besloten vennootschap met beperkte aansprakelijkheid) (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom WallachBeth Capital LLC is acting as Representative (the “Representative”), an aggregate of [●] Units (the “Firm Units”), each Firm Unit consisting of: (i) [ ] American Depositary Shares (the “ADSs”), with each ADS representing [ ] ordinary shares, nominal value €0.01 per share (the “Firm ADSs”); (ii) one tradeable warrant to purchase [ ] ADS (the “Firm Tradeable Warrants”); and, one non-tradeable warrant to purchase [ ] ADS (the “Firm Non-tradeable Warrants” and together with the Firm Tradeable Warrants, the “Firm Warrants”). The [●] ADSs to in this Section are hereinafter referred to as the “Firm Shares” together with the Firm Units
LYTUS TECHNOLOGIES HOLDINGS PTV LTD UNDERWRITING AGREEMENTUnderwriting Agreement • March 28th, 2022 • Lytus Technologies Holdings PTV. Ltd. • Services-computer processing & data preparation • New York
LYTUS TECHNOLOGIES HOLDINGS PTV LTD, a British Virgin Islands corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Aegis Capital Corp. is acting as representative (the “Representative”), an aggregate of [___] units (each, a “Unit”), with each Unit consisting of one common share, par value $0.01 per share (each, a “Common Share”), and one warrant (each, a “Warrant”) to purchase one Common Share at an exercise price of $[__] for a period of [_] ([_]) years, subject to adjustment as provided in the Warrant with the rights and privileges set forth in a warrant agreement (the “Warrant Agreement”). The Common Shares that included within the Units are hereinafter referred to as the “Firm Shares,” and the Warrants that are included within the Units are hereinafter referred to as the “Firm Warrants.” No Units will be certificated, and th
MOBIQUITY TECHNOLOGIES, INC. UNDERWRITING AGREEMENT [●] Firm UnitsUnderwriting Agreement • November 24th, 2021 • Mobiquity Technologies, Inc. • Services-advertising • New York
Mobiquity Technologies, Inc., a New York State corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Spartan Capital Securities, LLC is acting as representative (the “Representative”), an aggregate of [●] units (the “Firm Units”), with each unit consisting of one share of common stock, par value $0.0001 per share (the “Common Stock”) of the Company (the “Firm Shares”), and a Warrant to purchase one share of Common Stock, at an exercise price of $[●] per share and with a term of five (5) years (the “Firm Warrants”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, in the aggregate, up to [●] additional shares of Common Stock representing 15% of the Firm Shares sold in the offering from the Company (the “Option Shares”) and/or up to [●] additional warrants to purcha
MOBIQUITY TECHNOLOGIES, INC. UNDERWRITING AGREEMENT [●] Firm UnitsUnderwriting Agreement • November 19th, 2021 • Mobiquity Technologies, Inc. • Services-advertising • New York
Mobiquity Technologies, Inc., a New York State corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Spartan Capital Securities, LLC is acting as representative (the “Representative”), an aggregate of [●] units (the “Firm Units”), with each unit consisting of one share of common stock, par value $0.0001 per share (the “Common Stock”) of the Company (the “Firm Shares”), and a Warrant to purchase one share of Common Stock, at an exercise price of $[●] per share and with a term of five (5) years (the “Firm Warrants”). The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, in the aggregate, up to [●] additional shares of Common Stock representing 15% of the Firm Shares sold in the offering from the Company (the “Option Shares”) and/or up to [●] additional warrants to purcha
Crown Electrokinetics Corp. UNDERWRITING AGREEMENT [●] Shares of Common StockUnderwriting Agreement • January 13th, 2021 • Crown Electrokinetics Corp. • Electronic components, nec • New York
Crown Electrokinetics Corp., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”), for whom Roth Capital Partners, LLC is acting as the representative (the “Representative”), an aggregate of [●] authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company. The Company also proposes to sell to the Underwriters, upon the terms and conditions set forth in Section 4 hereof, up to an additional [●] shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”. The Shares, the Underwriter Warrants (as defined below) and the Underwriter Warrant Shares (as defined below) are collectively referred to as the “Securities”.
Underwriting AgreementUnderwriting Agreement • September 24th, 2019 • Vaxart, Inc. • Biological products, (no disgnostic substances) • New York
Vaxart, Inc., Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of (a) [·] shares of common stock (the “Firm Shares”), par value $0.10 per share, of the Company (the “Common Stock”), (b) [·] pre-funded warrants to purchase [·] shares of Common Stock at an exercise price of $0.10 per share (the “Pre-Funded Warrants”) and (c) warrants to purchase [·] shares of Common Stock at an exercise price of $[·] per share (the “Common Warrants” and, collectively with the Pre-Funded Warrants and the Firm Shares, the “Firm Securities”). The amount and form of the Firm Securities to be purchased by the Underwriters is set forth opposite its name on Schedule A hereto. The Company also proposes to sell to the Underwriters, at the option of the Underwriters, up to (i) an additional [·] shares of Common Stock (the “Option Shares”), (ii) [·] Common Warrants (the “Option Warrants”), and, to the Repre
